10 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
18337097	64	Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.	Abbott Bioresearch Center
22130135	55	Discovery of potent and specific CXCR3 antagonists.	Amgen
21764306	149	Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.	Novartis Institutes For Biomedical Research
21277198	71	II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.	Ligand Pharmaceuticals
19632842	65	Optimization of a series of quinazolinone-derived antagonists of CXCR3.	Amgen
19631529	74	Imidazo-pyrazine derivatives as potent CXCR3 antagonists.	Amgen
19783143	65	Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.	Novartis Institutes For Biomedical Research
19014886	83	Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.	Glaxosmithkline
18032038	38	Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.	Ucb Pharma
17097877	40	Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.	Ucb Pharma